Noelle K. LoConte
University of Wisconsin-Madison
EpidemiologyCancerInternal medicineSurgeryOncologyChemotherapyCapecitabineMEDLINEPancreatic cancerOxaliplatinAdenocarcinomaRegimenIn patientPhases of clinical researchCancer researchColorectal cancerBreast cancerClinical trialMedicinePharmacology
145Publications
25H-index
3,173Citations
Publications 142
Newest
#1Susan M. GapsturH-Index: 105
#2Elisa V. Bandera (RU: Rutgers University)H-Index: 64
Last. Kevin D. Shield (CAMH: Centre for Addiction and Mental Health)H-Index: 48
view all 10 authors...
Alcoholic beverages are carcinogenic to humans. Globally, an estimated 4.1% of new cancer cases in 2020 were attributable to alcoholic beverages. However, the full cancer-burden due to alcohol is uncertain because for many cancer (sub)types associations remain inconclusive. Additionally, associations of consumption with therapeutic response, disease progression, and long-term cancer outcomes are not fully understood, public awareness of the alcohol-cancer link is low, and the interrelationships ...
Source
#1Jeremy D. Kratz (UW: University of Wisconsin-Madison)H-Index: 7
#2Shujah Rehman (Morgridge Institute for Research)H-Index: 2
Last. Dustin A. DemingH-Index: 22
view all 34 authors...
Abstract null Tumor heterogeneity is predicted to confer inferior clinical outcomes, however modeling heterogeneity in a manner that still represents the tumor of origin remains a formidable challenge. Sequencing technologies are limited in their ability to identify rare subclonal populations and predict response to the multitude of available treatments for patients. Patient-derived organotypic cultures have significantly improved the modeling of cancer biology by faithfully representing the mol...
Source
#1Alexandria Cull Weatherer (UW: University of Wisconsin-Madison)
#2John K. Krebsbach (UW: University of Wisconsin-Madison)H-Index: 3
Last. Noelle K. LoConte (UW: University of Wisconsin-Madison)H-Index: 25
view all 5 authors...
As the number of cancer survivors grows, the responsibility for addressing their unique physical and emotional needs also increases. Survivorship care services vary by geography, health system, and insurance coverage. We aimed to understand the state of survivorship care services in Wisconsin’s cancer facilities. The selection of cancer treatment facilities sought to provide a geographically representative sample. An adapted Patient-Centered Survivorship Care Index was comprised of questions reg...
Source
#1Amye J. Tevaarwerk (UW: University of Wisconsin-Madison)H-Index: 21
#2Kris Kwekkeboom (UW: University of Wisconsin-Madison)H-Index: 2
Last. Ranveer NanadH-Index: 2
view all 15 authors...
Source
Source
Source
Source
#1Alexandria Cull Weatherer (UW: University of Wisconsin-Madison)
#2Stephanie L Pritzl (UW: University of Wisconsin-Madison)
Last. Noelle K. LoConte (UW: University of Wisconsin-Madison)H-Index: 25
view all 5 authors...
Background Human papillomavirus (HPV) is a recognized cause of cancer in both males and females. HPV vaccination prevents development of HPV-associated diseases. Methods Wisconsin HPV vaccination rates (2016-2019) were obtained from the Wisconsin Immunization Registry. Data was stratified by age, sex, Medicaid status, race/ethnicity, and ZIP code. Wisconsin vaccination rates were compared with national trends using data from the 2016, 2018, and 2019 National Immunization Survey-Teen. Results Wis...
#1Margaret A. Tempero (UCSF: University of California, San Francisco)H-Index: 59
#2Mokenge P. Malafa (Moffitt Cancer Center)H-Index: 21
Last. Giby V George (National Comprehensive Cancer Network)H-Index: 2
view all 36 authors...
Pancreatic cancer is the fourth leading cause of cancer-related death among men and women in the United States. A major challenge in treatment remains patients' advanced disease at diagnosis. The NCCN Guidelines for Pancreatic Adenocarcinoma provides recommendations for the diagnosis, evaluation, treatment, and follow-up for patients with pancreatic cancer. Although survival rates remain relatively unchanged, newer modalities of treatment, including targeted therapies, provide hope for improving...
Source
#1Amye J. Tevaarwerk (UW: University of Wisconsin-Madison)H-Index: 21
#2Kris Kwekkeboom (UW: University of Wisconsin-Madison)H-Index: 2
Last. Mary E. Sesto (UW: University of Wisconsin-Madison)H-Index: 18
view all 15 authors...
Background Postcancer work limitations may affect a substantial proportion of patients and contribute to the "financial toxicity" of cancer treatment. The degree and nature of work limitations and employment outcomes are poorly understood for cancer patients, particularly in the immediate period of transition after active treatment. We prospectively examined employment, work ability, and work limitations during and after treatment. Methods A total of 120 patients receiving curative therapy who w...
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.